| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.024 | 0.6 |